Insurance plans must cover breast cancer preventive medications
Posted on January 9, 2014 | Comment (1)
According to a set of FAQ’s issued by the Center for Consumer Information and Insurance Oversight (CCIIO), insurers are now required to fully cover medications that help reduce the incidence of breast cancer among women at high risk. Examples of these medications include tamoxifen and raloxifene. The policy change, arising from recommendations by the US Preventive Services Task Force (USPSTF), was decided in September 2013 and goes into effect for plan years beginning on or after September 24th, 2014.